Acute lymphoblastic leukaemia

21


Acute lymphoblastic leukaemia


Acute lymphoblastic leukaemia (ALL) is a clonal malignancy of lymphoid precursor cells. In over 80% of cases the malignant cells are primitive precursors of B-lymphocytes and the remainder are T-cell leukaemias. The abnormal cell may arise at various stages of early lymphocyte differentiation (see p. 8).


ALL has a peak incidence in childhood with a gradual rise in incidence in later years (Fig 21.1). The disease has distinct characteristics in children and adults. Childhood ALL is often curable by chemotherapy whereas cure is elusive in adult ALL. Poorer outcome in adult ALL is due to a combination of a greater frequency of high-risk leukaemia with more drug resistance, and less effective treatment regimens.




Classification


The French-American-British (FAB) morphological classification is based on characteristics of the blast cells, including cell size, nuclear–cytoplasmic ratio, number and size of nucleoli and the degree of cytoplasmic basophilia (Fig 21.2). Morphological classification is now less important than that based on immunophenotyping, cytogenetics and molecular analysis (Table 21.1).




Definition of the immunological subtypes of ALL depends on the presence or absence of various cell surface and cytoplasmic antigens. A commonly used classification divides ALL into early pre-B, pre-B, B-cell and T-cell subtypes. Mature B-cell ALL typically has L3 morphology. The current WHO classification divides most ALL subtypes into B- or T-lymphoblastic leukaemia/lymphoma under the heading ‘precursor lymphoid neoplasms’. Mature B-ALL is included as Burkitt lymphoma.


In the selection of treatment it is important to differentiate between three broad groups; T-cell ALL, mature B-ALL and all other types of B-lineage ALL. Genetic abnormalities are becoming increasingly important in classification of ALL as they give vital prognostic information (Table 21.2).



Table 21.2


Chromosomal abnormalities in ALL













































Only gold members can continue reading. Log In or Register to continue

Related posts:

Other leukaemias Acute myeloid leukaemia Myeloma Thrombocytopenia Venepuncture and venous access Hodgkin’s lymphoma

Stay updated, free articles. Join our Telegram channel

Tags:
Jun 12, 2016 | Posted by in HEMATOLOGY | Comments Off on Acute lymphoblastic leukaemia

Full access? Get Clinical Tree

 Get Clinical Tree app for offline access
Abnormality   Prognostic significance
Numerical change    
High hyperdiploidy (over 50 chromosomes)   Favourable
Hyperdiploidy (47–50)   Intermediate
Pseudodiploidy (46 with structural/numerical change)   Intermediate
Hypodiploidy (less than 46)   Poor
Structural abnormality Genes involved  
Philadelphia chromosome, t(9;22)1 BCR-ABL Poor
t(12;21)2 TEL-AML1 (ETV6-RUNX1) Good
t(1;19) E2A-PBX1 Good
t(v;11q23)